Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodococcus erythropolis AJ270. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101898990B details Rhodococcus erythropolis AJ270 catalyzed hydrolysis for high-purity chiral azetidine intermediates, offering cost-effective scalable manufacturing solutions.
Patent CN114957030B reveals Rhodococcus erythropolis AJ270 catalyzed hydrolysis for high-purity chiral intermediates, offering cost reduction and supply chain reliability.